Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis
Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. All patients who underwent temporal...
Saved in:
Published in | Rheumatology (Oxford, England) Vol. 54; no. 3; pp. 554 - 558 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.03.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1462-0324 1462-0332 1462-0332 |
DOI | 10.1093/rheumatology/keu364 |
Cover
Loading…
Abstract | Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA.
All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6.
Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone.
Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB. |
---|---|
AbstractList | Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA.OBJECTIVEAberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA.All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6.METHODSAll patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6.Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone.RESULTSNineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone.Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.CONCLUSIONSubjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB. Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6. Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone. Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB. Objective. Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. Methods. All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0–2, with a maximum possible score of 6. Results. Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores ( P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone. Conclusion. Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB. |
Author | Pernis, A. Huang, W.-T. Narula, N. Spiera, R. Lally, L. |
Author_xml | – sequence: 1 givenname: L. surname: Lally fullname: Lally, L. – sequence: 2 givenname: A. surname: Pernis fullname: Pernis, A. – sequence: 3 givenname: N. surname: Narula fullname: Narula, N. – sequence: 4 givenname: W.-T. surname: Huang fullname: Huang, W.-T. – sequence: 5 givenname: R. surname: Spiera fullname: Spiera, R. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25213129$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UUtP3DAQthAV719QqfKRy4IfSRxfkBCiBQmpl3K2HGe8a0jsYDug_fd4tQuiPfQ0I833mJnvGO374AGh75RcUCL5ZVzBPOochrBcXz7DzJtqDx3RqmELwjnb_-xZdYiOU3oihNSUtwfokNWMcsrkEdL33kTQCXocVwE_O196rE12ry6vsfM4wziFqAesY4a4xp0LU3KQsI1hxJPODnxO-M3lFV467TM2MOzQLrt0ir5ZPSQ429UT9Pjz9s_N3eLh96_7m-uHhalEnRc1CGBUV7WwDSHQMclkp4WRxra257ZvC0DUQojeGCsEF6SXkrbUdswIIfkJutrqTnM3Qm_KVmVrNUU36rhWQTv198S7lVqGV1VxXjVtXQTOdwIxvMyQshpd2tyiPYQ5KdrUgjPeEFGgP756fZp8_LUA5BZgYkgpglXG5fKqsLF2g6JEbTJUXzNU2wwLl__D_ZD_H-sdIG6qWw |
CitedBy_id | crossref_primary_10_1080_14737175_2017_1395700 crossref_primary_10_1016_j_berh_2016_05_001 crossref_primary_10_1007_s40266_015_0284_7 crossref_primary_10_1080_14397595_2016_1266070 crossref_primary_10_1146_annurev_med_051914_022120 crossref_primary_10_12688_f1000research_7522_1 crossref_primary_10_1097_BOR_0000000000000265 crossref_primary_10_1016_j_rdc_2014_10_001 crossref_primary_10_1016_j_clim_2021_108823 crossref_primary_10_1016_j_autrev_2023_103328 crossref_primary_10_1016_j_lpm_2016_11_033 crossref_primary_10_3899_jrheum_220012 crossref_primary_10_3904_kjm_2018_93_5_430 |
Cites_doi | 10.1152/ajpheart.00327.2011 10.1038/sj.eye.6700677 10.1253/circj.CJ-10-0110 10.1053/sarh.2001.16650 10.1016/S1568-9972(03)00064-8 10.1002/art.33362 10.4049/jimmunol.178.3.1938 10.1016/S0140-6736(08)61077-6 10.1083/jcb.140.3.647 10.1172/JCI42856 10.4065/79.4.483 10.1097/BOR.0b013e32833ee946 10.1007/s00018-010-0460-1 10.1002/art.34327 10.7326/0003-4819-142-5-200503010-00011 10.1111/j.0105-2896.2009.00864.x 10.1002/art.1780330810 10.1136/ard.2008.088351 10.1002/art.11388 10.1136/annrheumdis-2012-201836 |
ContentType | Journal Article |
Copyright | The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014 |
Copyright_xml | – notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. – notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1093/rheumatology/keu364 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1462-0332 |
EndPage | 558 |
ExternalDocumentID | PMC4334685 25213129 10_1093_rheumatology_keu364 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: T32 AR007517 – fundername: NIAMS NIH HHS grantid: T32-AR007517-30 |
GroupedDBID | --- -E4 .2P .I3 .XZ .ZR 08P 0R~ 18M 1TH 29P 2WC 354 4.4 48X 53G 5RE 5VS 5WA 5WD 70D AABZA AACZT AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWTL AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACGFO ACGFS ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGORE AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CITATION CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MHKGH N9A NGC NOMLY NOYVH NU- NVLIB O9- OAUYM OAWHX OBH OCZFY ODMLO OHH OJQWA OJZSN OPAEJ OVD OWPYF P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX RUSNO RW1 RXO SV3 TCURE TEORI TJX TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ZY1 ~91 .GJ 3O- AAGKA AAPGJ AAWDT ABNGD ACFRR ACUKT ADMTO AEHUL AFFNX AGQPQ AHGBF AQDSO ATTQO AZFZN CAG CGR COF CUY CVF ECM EIF EIHJH FEDTE HVGLF NPM NTWIH O0~ O~Y PB- RIG RNI RZF RZO TMA ZGI 7X8 5PM |
ID | FETCH-LOGICAL-c475t-5e7e21a457f600eb2929ba7c9cf8fd3fd8e7e75777dccf77370d99181fb2c7793 |
ISSN | 1462-0324 1462-0332 |
IngestDate | Thu Aug 21 18:02:51 EDT 2025 Thu Jul 10 17:02:08 EDT 2025 Mon Jul 21 05:37:42 EDT 2025 Tue Jul 01 01:36:32 EDT 2025 Thu Apr 24 23:10:16 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | giant cell arteritis vasculitis rho-associated kinases |
Language | English |
License | The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c475t-5e7e21a457f600eb2929ba7c9cf8fd3fd8e7e75777dccf77370d99181fb2c7793 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/rheumatology/article-pdf/54/3/554/6700289/keu364.pdf |
PMID | 25213129 |
PQID | 1657323607 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4334685 proquest_miscellaneous_1657323607 pubmed_primary_25213129 crossref_citationtrail_10_1093_rheumatology_keu364 crossref_primary_10_1093_rheumatology_keu364 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-03-01 |
PublicationDateYYYYMMDD | 2015-03-01 |
PublicationDate_xml | – month: 03 year: 2015 text: 2015-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Rheumatology (Oxford, England) |
PublicationTitleAlternate | Rheumatology (Oxford) |
PublicationYear | 2015 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | (11_48541577) 2011; 301 (9_35806208) 1998; 140 Hunder (13_9148981) 1990; 33 Varma (15_18126353) 2004; 18 Karassa (17_18707055) 2005; 142 (2_30897245) 2009; 68 Weyand (3_38110435) 2011; 23 Restuccia (20_40870751) 2012; 64 Biswas (7_36736544) 2010; 233 Proven (18_17855780) 2003; 49 Gonzalez-Gay (16_11044191) 2001; 30 Nunes (10_37743196) 2010; 67 Younge (14_18123319) 2004; 79 Weyand (19_18036490) 2004; 3 (4_43646735) 2013; 72 Li (8_23536804) 2007; 178 Terrier (5_41400410) 2012; 64 Zhou (12_37189433) 2010; 74 Salvarani (1_31572308) 2008; 372 Biswas (6_37892137) 2010; 120 14871649 - Autoimmun Rev. 2004 Jan;3(1):46-53 15069435 - Eye (Lond). 2004 Apr;18(4):384-8 18640460 - Lancet. 2008 Jul 19;372(9634):234-45 15065613 - Mayo Clin Proc. 2004 Apr;79(4):483-91 21953306 - Arthritis Rheum. 2012 Feb;64(2):549-56 22993227 - Ann Rheum Dis. 2013 Sep 1;72(9):1481-7 14558057 - Arthritis Rheum. 2003 Oct 15;49(5):703-8 11182025 - Semin Arthritis Rheum. 2001 Feb;30(4):249-56 9456324 - J Cell Biol. 1998 Feb 9;140(3):647-57 21622831 - Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96 2202311 - Arthritis Rheum. 1990 Aug;33(8):1122-8 18413441 - Ann Rheum Dis. 2009 Mar;68(3):318-23 20697158 - J Clin Invest. 2010 Sep;120(9):3280-95 20668910 - Cell Mol Life Sci. 2010 Nov;67(22):3823-36 20192994 - Immunol Rev. 2010 Jan;233(1):79-96 20424337 - Circ J. 2010 May;74(5):818-26 22147555 - Arthritis Rheum. 2012 Jun;64(6):2001-11 15738455 - Ann Intern Med. 2005 Mar 1;142(5):359-69 20827207 - Curr Opin Rheumatol. 2011 Jan;23(1):43-9 17237445 - J Immunol. 2007 Feb 1;178(3):1938-47 |
References_xml | – volume: 301 start-page: 287 issn: 0363-6135 year: 2011 ident: 11_48541577 publication-title: American Journal of Physiology - Heart and Circulatory Physiology doi: 10.1152/ajpheart.00327.2011 – volume: 18 start-page: 384 issn: 0950-222X issue: 4 year: 2004 ident: 15_18126353 publication-title: Eye (London, England) doi: 10.1038/sj.eye.6700677 – volume: 74 start-page: 818 issn: 1346-9843 issue: 5 year: 2010 ident: 12_37189433 publication-title: Circulation journal : official journal of the Japanese Circulation Society doi: 10.1253/circj.CJ-10-0110 – volume: 30 start-page: 249 issn: 0049-0172 issue: 4 year: 2001 ident: 16_11044191 publication-title: Seminars in arthritis and rheumatism doi: 10.1053/sarh.2001.16650 – volume: 3 start-page: 46 issn: 1568-9972 issue: 1 year: 2004 ident: 19_18036490 publication-title: Autoimmunity reviews doi: 10.1016/S1568-9972(03)00064-8 – volume: 64 start-page: 549 issn: 0004-3591 issue: 2 year: 2012 ident: 20_40870751 publication-title: Arthritis and rheumatism doi: 10.1002/art.33362 – volume: 178 start-page: 1938 issn: 0022-1767 issue: 3 year: 2007 ident: 8_23536804 publication-title: The Journal of Immunology doi: 10.4049/jimmunol.178.3.1938 – volume: 372 start-page: 234 issn: 0140-6736 issue: 9634 year: 2008 ident: 1_31572308 publication-title: Lancet doi: 10.1016/S0140-6736(08)61077-6 – volume: 140 start-page: 647 issn: 0021-9525 issue: 3 year: 1998 ident: 9_35806208 publication-title: The Journal of Cell Biology doi: 10.1083/jcb.140.3.647 – volume: 120 start-page: 3280 issn: 0021-9738 issue: 9 year: 2010 ident: 6_37892137 publication-title: Journal of Clinical Investigation doi: 10.1172/JCI42856 – volume: 79 start-page: 483 issn: 0025-6196 issue: 4 year: 2004 ident: 14_18123319 publication-title: Mayo Clinic Proceedings doi: 10.4065/79.4.483 – volume: 23 start-page: 43 issn: 1040-8711 issue: 1 year: 2011 ident: 3_38110435 publication-title: Current opinion in rheumatology doi: 10.1097/BOR.0b013e32833ee946 – volume: 67 start-page: 3823 issn: 1420-682X issue: 22 year: 2010 ident: 10_37743196 publication-title: Cellular and molecular life sciences : CMLS doi: 10.1007/s00018-010-0460-1 – volume: 64 start-page: 2001 issn: 0004-3591 issue: 6 year: 2012 ident: 5_41400410 publication-title: Arthritis and rheumatism doi: 10.1002/art.34327 – volume: 142 start-page: 359 issn: 0003-4819 issue: 5 year: 2005 ident: 17_18707055 publication-title: Annals of Internal Medicine doi: 10.7326/0003-4819-142-5-200503010-00011 – volume: 233 start-page: 79 issn: 0105-2896 issue: 1 year: 2010 ident: 7_36736544 publication-title: Immunological reviews doi: 10.1111/j.0105-2896.2009.00864.x – volume: 33 start-page: 1122 issn: 0004-3591 issue: 8 year: 1990 ident: 13_9148981 publication-title: Arthritis and rheumatism doi: 10.1002/art.1780330810 – volume: 68 start-page: 318 issn: 0003-4967 issue: 3 year: 2009 ident: 2_30897245 publication-title: Annals of the Rheumatic Diseases doi: 10.1136/ard.2008.088351 – volume: 49 start-page: 703 issn: 0004-3591 issue: 5 year: 2003 ident: 18_17855780 publication-title: Arthritis and rheumatism doi: 10.1002/art.11388 – volume: 72 start-page: 1481 issn: 0003-4967 issue: 9 year: 2013 ident: 4_43646735 publication-title: Annals of the Rheumatic Diseases doi: 10.1136/annrheumdis-2012-201836 – reference: 15065613 - Mayo Clin Proc. 2004 Apr;79(4):483-91 – reference: 14871649 - Autoimmun Rev. 2004 Jan;3(1):46-53 – reference: 21953306 - Arthritis Rheum. 2012 Feb;64(2):549-56 – reference: 22993227 - Ann Rheum Dis. 2013 Sep 1;72(9):1481-7 – reference: 9456324 - J Cell Biol. 1998 Feb 9;140(3):647-57 – reference: 17237445 - J Immunol. 2007 Feb 1;178(3):1938-47 – reference: 15069435 - Eye (Lond). 2004 Apr;18(4):384-8 – reference: 2202311 - Arthritis Rheum. 1990 Aug;33(8):1122-8 – reference: 20424337 - Circ J. 2010 May;74(5):818-26 – reference: 21622831 - Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96 – reference: 18640460 - Lancet. 2008 Jul 19;372(9634):234-45 – reference: 20192994 - Immunol Rev. 2010 Jan;233(1):79-96 – reference: 14558057 - Arthritis Rheum. 2003 Oct 15;49(5):703-8 – reference: 20668910 - Cell Mol Life Sci. 2010 Nov;67(22):3823-36 – reference: 20827207 - Curr Opin Rheumatol. 2011 Jan;23(1):43-9 – reference: 18413441 - Ann Rheum Dis. 2009 Mar;68(3):318-23 – reference: 15738455 - Ann Intern Med. 2005 Mar 1;142(5):359-69 – reference: 22147555 - Arthritis Rheum. 2012 Jun;64(6):2001-11 – reference: 11182025 - Semin Arthritis Rheum. 2001 Feb;30(4):249-56 – reference: 20697158 - J Clin Invest. 2010 Sep;120(9):3280-95 |
SSID | ssj0005138 |
Score | 2.2226698 |
Snippet | Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune... Objective. Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 554 |
SubjectTerms | Aged Aged, 80 and over Basic and Translational Science Biomarkers - metabolism Biopsy Case-Control Studies Cell Differentiation Cytoskeletal Proteins - metabolism Female Giant Cell Arteritis - diagnosis Giant Cell Arteritis - metabolism Giant Cell Arteritis - pathology Humans Male Membrane Proteins - metabolism Microfilament Proteins - metabolism Predictive Value of Tests rho-Associated Kinases - metabolism Sensitivity and Specificity Temporal Arteries - metabolism Temporal Arteries - pathology Th17 Cells - pathology |
Title | Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25213129 https://www.proquest.com/docview/1657323607 https://pubmed.ncbi.nlm.nih.gov/PMC4334685 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvaHyXDWQk3kqyxh9x-jghYELbHlAn-hY5jkOrVemUJRLbP8K_yzl2EndME-MlShz3lPp-OZ-du98h9EHoWUaLnAXTTMUB44oFMK-TgEkOzkUki2mbKHxyGh-dsW8LvhiNfntRS02dher61ryS_9EqtIFeTZbsPTTbC4UGOAf9whE0DMd_0jG83CamHHzGarmZnK9KOG_ZMdqCECaC0RJPrSdt5ObVJFttLi5hbWyzShynqktw-wlAqSdmI9_2NmRHvuv6fakbcG8tZ5MhKf3VxcW7QiDepsKxdBWsj8PB9lalK33ct53KqllLm_A14MvtYP8Ig3nob0pEfIjKcnaUxQTabHp0qP02umV8LYO0Axn1LCl3d7S7Sm6195YLq_IGAC7PdUNjNkxw3Uf9G_NeH41ov8PT1BeTWiEP0EMC6w9TGuPrwosditoS6f2_7OisZvTAF3JghWy7PH-tY26G43r-zXwXPXELE3xoUfYUjXT5DD06caEXz5HswYYBbNiCDXdgw6sSd2DDFmy4Axs2YMMd2LABG27Bhg3YcA-2F-jsy-f5p6PA1ecIFBO8DrgWmkSScVGA26wzAq52JoWaqSIpcrAACXQQXAiRK1UIQcU0h-VIEhUZUQImhpdop9yU-jXCOorihLKCkVwaFxNkybxguY4zaZJYx4h0Q5gqR15vaqis0zuUN0Yf-x9dWO6Wu7u_73STgo01QyBLvWku0yjmghIaT8UYvbK66gUS8H8pOM1jJLa02Hcw_O3bd8rVsuVxZ5SyOOFv7veYe-jx8Mbto526avRbcIzr7F0L0j8UjMT3 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+rho+kinase+activity+in+temporal+artery+biopsies+from+patients+with+giant+cell+arteritis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Lally%2C+L.&rft.au=Pernis%2C+A.&rft.au=Narula%2C+N.&rft.au=Huang%2C+W.-T.&rft.date=2015-03-01&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=54&rft.issue=3&rft.spage=554&rft.epage=558&rft_id=info:doi/10.1093%2Frheumatology%2Fkeu364&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_rheumatology_keu364 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon |